跳至主要内容
临床试验/NCT05141643
NCT05141643进行中(未招募)1 期

18F-FAC PET Imaging to Quantify Gemcitabine Tumor Drug Uptake and Biodistribution in Pancreatic Cancer Patients

Memorial Sloan Kettering Cancer Center2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年11月18日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
30
试验地点
2
主要终点
Tumor drug uptake within PDAC tumors prior at pre-treatment baseline

研究概览

简要总结

The purpose of this study is to find out whether a pre-treatment PET scan using the experimental imaging tracer 18F-FAC can show how much of the standard chemotherapy for PDAC may be taken up by the cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with histologically-confirmed (confirmed at MSKCC) PDAC
  • Patients must be ≥ 18 years old
  • Signed, written Institutional Review Board (IRB)-approved Informed Consent Form (ICF).
  • Measurable or evaluable solid disease on computed tomography (CT) or magnetic resonance imaging (MRI) scan per RECIST v1.
  • Karnofsky Performance Status ≥70%.
  • Life expectancy ≥3 months.
  • A negative serum pregnancy test, within 1 week of the procedure, if the patient is female of reproductive potential.

排除标准

  • Patients who cannot undergo PET/CT scanning (i.e. because of weight limits, claustrophobia).
  • Women who are pregnant or breast-feeding.

研究组 & 干预措施

Participants with pancreatic ductal adenocarcinoma (PDAC)

Experimental

Participants will have histologically-confirmed pancreatic ductal adenocarcinoma (PDAC). The experimental design of this study is to perform a single [18F]-FAC PET scan prior to the administration of chemotherapy with an optional second [18F]-FAC PET scan procedure during SOC treatment to observe changes in tumor uptake and biodistribution. Patients will be offered a second [18F]-FAC PET scan procedure during their SOC treatment. This second scan will be optional.

干预措施: PET Scan (Diagnostic Test)

结局指标

主要结局

Tumor drug uptake within PDAC tumors prior at pre-treatment baseline

时间窗: Baseline

The primary objective of this study is to obtain preliminary data of tumor drug uptake profile, concentration and distribution within PDAC tumors prior at pre-treatment baseline

次要结局

  • changes in [18F]-FAC drug uptake during or following SOC chemo- and/or radiation therapy.(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验